SI-BONE, Inc. (SIBN)
18.08
-0.33
(-1.79%)
USD |
NASDAQ |
Oct 02, 16:00
18.08
0.00 (0.00%)
Pre-Market: 20:00
SI-BONE Profit Margin (Quarterly) : -7.30% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.30% |
| March 31, 2026 | -8.24% |
| December 31, 2025 | -2.92% |
| September 30, 2025 | -9.38% |
| June 30, 2025 | -12.65% |
| March 31, 2025 | -13.83% |
| December 31, 2024 | -9.18% |
| September 30, 2024 | -16.30% |
| June 30, 2024 | -22.36% |
| March 31, 2024 | -28.80% |
| December 31, 2023 | -28.26% |
| September 30, 2023 | -29.46% |
| June 30, 2023 | -33.65% |
| March 31, 2023 | -34.01% |
| December 31, 2022 | -34.97% |
| September 30, 2022 | -53.56% |
| June 30, 2022 | -72.36% |
| March 31, 2022 | -77.59% |
| December 31, 2021 | -57.38% |
| September 30, 2021 | -71.22% |
| June 30, 2021 | -62.99% |
| March 31, 2021 | -59.89% |
| Date | Value |
|---|---|
| December 31, 2020 | -40.55% |
| September 30, 2020 | -46.50% |
| June 30, 2020 | -88.78% |
| March 31, 2020 | -75.93% |
| December 31, 2019 | -45.92% |
| September 30, 2019 | -69.87% |
| June 30, 2019 | -53.04% |
| March 31, 2019 | -62.34% |
| December 31, 2018 | -33.99% |
| September 30, 2018 | -35.81% |
| December 31, 2017 | -35.62% |
| September 30, 2017 | -48.64% |
| June 30, 2017 | -52.79% |
| March 31, 2017 | -57.67% |
| March 31, 2016 | -69.26% |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | -73.55% |
| December 31, 2014 | -80.13% |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | -35.83% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 7.37% |
| AngioDynamics, Inc. | -13.17% |
| Alphatec Holdings, Inc. | -12.07% |
| AtriCure, Inc. | 5.83% |
| Baxter International, Inc. | 4.56% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -8.30% |
| Return on Assets | -6.12% |
| Return on Invested Capital | -6.79% |
| Gross Profit Margin (Quarterly) | 79.54% |
| Operating Margin (Quarterly) | -8.58% |
| Return on Net Operating Assets | -16.24% |